Patients treated for congestive heart failure (CHF) by noncardiologists face a greater risk of not receiving lifesaving prescription therapy for their condition, according to a new study published in the American Journal of Health- System Pharmacy.
The drugs in questionbeta-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and aldosterone antagonistshave all been shown to significantly decrease morbidity and mortality, and are among the medications recommended by the Heart Failure Society of America to treat CHF, hospital pharmacy leaders explained.
But in a study examining prescribing differences by medical specialty, researchers discovered that:
Mr. Rankin is a freelance medical writer.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs